Page last updated: 2024-08-22

cladribine and Herpes Zoster

cladribine has been researched along with Herpes Zoster in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Comi, G; Cook, S; Galazka, A; Giovannoni, G; Hicking, C; Leist, T; Montalban, X; Nolting, A; Sylvester, E	1
Chang, P; Comi, G; Cook, S; Giovannoni, G; Greenberg, SJ; Hamlett, A; Musch, B; Rammohan, K; Rieckmann, P; Soelberg Sørensen, P; Vermersch, P	1
Comi, G; Cook, S; Giovannoni, G; Greenberg, SJ; Hamlett, A; Miret, M; Musch, B; Rammohan, K; Rieckmann, P; Sørensen, PS; Vermersch, P; Viglietta, V; Weiner, J	1
Li, CY; Pardanani, A; Phyliky, RL; Tefferi, A	1

Trials

2 trial(s) available for cladribine and Herpes Zoster

Article	Year
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. The New England journal of medicine, 2010, Feb-04, Volume: 362, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Aged; Analysis of Variance; Brain; Cladribine; Disability Evaluation; Disease Progression; Double-Blind Method; Female; Herpes Zoster; Humans; Immunosuppressive Agents; Intention to Treat Analysis; Lymphopenia; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Young Adult	2010
Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study. Multiple sclerosis (Houndmills, Basingstoke, England), 2011, Volume: 17, Issue:5 Topics: Administration, Oral; Adult; Cladribine; Disability Evaluation; Double-Blind Method; Europe; Herpes Zoster; Humans; Immunosuppressive Agents; Lymphopenia; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Neoplasms; Neurologic Examination; Physical Examination; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; United States; Young Adult	2011

Article

Year

A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.

The New England journal of medicine, 2010, Feb-04, Volume: 362, Issue:5

Topics: Administration, Oral; Adolescent; Adult; Aged; Analysis of Variance; Brain; Cladribine; Disability Evaluation; Disease Progression; Double-Blind Method; Female; Herpes Zoster; Humans; Immunosuppressive Agents; Intention to Treat Analysis; Lymphopenia; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Young Adult

2010

Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study.

Multiple sclerosis (Houndmills, Basingstoke, England), 2011, Volume: 17, Issue:5

Topics: Administration, Oral; Adult; Cladribine; Disability Evaluation; Double-Blind Method; Europe; Herpes Zoster; Humans; Immunosuppressive Agents; Lymphopenia; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Neoplasms; Neurologic Examination; Physical Examination; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; United States; Young Adult

2011

Other Studies

2 other study(ies) available for cladribine and Herpes Zoster

Article	Year
Safety of cladribine tablets in the treatment of patients with multiple sclerosis: An integrated analysis. Multiple sclerosis and related disorders, 2019, Volume: 29 Topics: Adolescent; Adult; Aged; Cladribine; Clinical Trials, Phase III as Topic; Cohort Studies; Drug-Related Side Effects and Adverse Reactions; Female; Herpes Zoster; Humans; Immunosuppressive Agents; Lymphopenia; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Registries; Young Adult	2019
2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis. Mayo Clinic proceedings, 2003, Volume: 78, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Brain Diseases; Cladribine; Female; Herpes Zoster; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies	2003

Article

Year

Safety of cladribine tablets in the treatment of patients with multiple sclerosis: An integrated analysis.

Multiple sclerosis and related disorders, 2019, Volume: 29

Topics: Adolescent; Adult; Aged; Cladribine; Clinical Trials, Phase III as Topic; Cohort Studies; Drug-Related Side Effects and Adverse Reactions; Female; Herpes Zoster; Humans; Immunosuppressive Agents; Lymphopenia; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Registries; Young Adult

2019

2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis.

Mayo Clinic proceedings, 2003, Volume: 78, Issue:3

Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Brain Diseases; Cladribine; Female; Herpes Zoster; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies

2003